Morocco latest patents query
The latest invention patents collect the data information of Morocco invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
PROCESSES FOR PRODUCING TUMOR-INFILTRATING LYMPHOCYTES AND THEIR USES IN IMMUNOTHERAPY
Owner:IOVANCE BIOTHERAPEUTICS INC
COMPLEX ANTI-ANGPTL3 / 8 ANTIBODIES AND ASSOCIATED METHODS OF USE
UndeterminedMA54527A
Owner:ELI LILLY & CO
FINE CUTTING DEVICE / NORMAL CUTTING OF RAW PRODUCTS FROM A METAL STRIP AS WELL AS MULTI-STAGE PROCESSING OF THE RAW PRODUCTS USING CUTTING AND SHAPING TOOLS
UndeterminedMA52715A
Owner:METEOR UMFORMTECHN
Lightweight automotive optical housing, optical block and body part
UndeterminedMA43523A
Owner:COMPAGNIE PLASTIC OMNIUM SA
ELECTROMAGNETIC HAMMER-TYPE DEVICE FOR THE MECHANICAL PROCESSING OF MATERIALS AND ITS METHOD OF USE
UndeterminedMA46220A
Owner:MORES STYLIANOS
VARIABLE FLUID INERTIA SUSPENSION DEVICE FOR A VEHICLE TRAIN
UndeterminedMA46831A
Owner:PSA AUTOMOBILES SA
VIDEO IMAGE PROCESSING METHOD AND DEVICE
UndeterminedMA50861A
Owner:TENCENT TECHNOLOGY (SHENZHEN) CO LTD
Method for manufacturing tubular articles provided with a grip region by way of circular hosiery knitting machines, and tubular article obtained with the method
Owner:CALZIFICIO PINELLI
INSTALLATION AND METHOD FOR THE AUTOMATIC MANUFACTURING OF PIPES
UndeterminedMA53389A
Owner:LEONI BORDNETZ-SYSTEME GMBH & CO KG
SURGICAL STAPLER WITH MOTOR CONTROL BASED ON A DRIVE SYSTEM COMPONENT
UndeterminedMA41329A
Owner:ETHICON INC
METHOD FOR PROVIDING SAFE ADMINISTRATION OF AN ANTI-CD40 ANTIBODY
UndeterminedMA56027A
Owner:JANSSEN BIOTECH INC
FORMES CRISTALLINES DE N-(5-(5-((1R, 2S)-2-FLUOROCYCLOPROPYL)-1,2,4-OXADIAZOL-3-YL)-2-METHYLPHENYL) IMIDAZO [1,2-A] PYRIDINE-3-CARBOXAMIDE
UndeterminedMA55976A
Owner:NOVARTIS AG
USE OF JAGGED 1 / FRIZZLED 4 AS CELL SURFACE MARKERS TO ISOLATE HUMAN CARDIAC VENTRICULAR PROGENITOR CELLS
UndeterminedMA40589A
Owner:PROCELLA THERAPEUTICS AB
Feed dispenser for breeding animals with improved feed level adjustment
UndeterminedMA52959A
Owner:CORTI ZOOTECNICI
AUTOMATED SELECTIVE HARVESTING WITH ASSOCIATED SYSTEMS AND PROCESSES
UndeterminedMA52100A
Owner:HARVEST CROO ROBOTICS LLC
KRAS MACROCYCLIC INHIBITORS FOR CANCER TREATMENT
UndeterminedMA71370A
Owner:F HOFFMANN LA ROCHE & CO AG
METHOD AND DEVICE FOR REAL-TIME MONITORING AND EVALUATION OF THE CONDITION OF A PATIENT WITH A NEUROLOGICAL DISORDER
UndeterminedMA53824A
Owner:MJN NEUROSERVEIS
Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c] pyrazole and 4,5,6,7-tetrahydro-2h-pyrazolo [4,3-c] pyridine compounds as glyt1 inhibitors
UndeterminedMA39888A
Owner:DART NEUROSCIENCE (CAYMAN) LTD(GB)
ANTITUMOR AGENT CONTAINING AN IMMUNOMODULATOR AND AN ANTITUMOR EFFECT AMPLIFIER
UndeterminedMA43590A
Owner:TAIHO PHARMA CO LTD
COMPOSITIONS AND METHODS OF TREATMENT OF IMMUNE THROMBOCYTOPENIA
UndeterminedMA52790A
Owner:ARGENX BVBA(BE)
COASTAL STRUCTURE AND WAVE CREATION METHOD FOR SURFING
UndeterminedMA41832A
Owner:FUNDACION AZTI AZTI FUNDAZIOA
METHODS FOR INCREASING PROTECTION AGAINST ORGAN AND VESSEL DAMAGE, HEMATOPOIETIC RECOVERY, AND SURVIVAL IN RESPONSE TO EXPOSURE TO TOTAL BODY IRRADIATION OR CHEMICAL AGENTS
UndeterminedMA54821A
Owner:JANSSEN PHARMA NV
PROCESSES FOR MANUFACTURING OPTICALLY EFFECTIVE COATINGS
Owner:SICPA HOLDING SA
CANCER TREATMENT METHODS WITH ANTI-PD-1 AND ANTI-CTLA4 ANTIBODIES
UndeterminedMA51844A
Owner:MERCK SHARP & DOHME CORP
DOSE REGULATION DEVICE FOR INJECTABLE DRUG ADMINISTRATION DEVICES
UndeterminedMA52016A
Owner:BIOCORP PRODUCTION SA
BENZOXABOROLE COMPOUNDS SUBSTITUTED AT POSITION 4 AND ASSOCIATED USES
Owner:GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD +1
RECEIVER FOR SOLAR POWER GENERATION INSTALLATIONS
UndeterminedMA43661A
Owner:DEUTSCHES ZENTRUM FÜR LUFT UND RAUMFAHRT E V
METHODS FOR TREATMENT OF B LYMPHOCYTE MALIGNITIES USING ADOPTIVE CELL THERAPY
UndeterminedMA45341A
Owner:FRED HUTCHINSON CANCER RESEARCH CENTER +1
Battery with cell group(s) and conversion module, to provide different voltages and perform different recharges
UndeterminedMA50139A
Owner:CENT NAT DE LA RECH SCI (C N R S) +2
EGF(A) ANALOGUES, PREPARATION, FORMULATIONS AND ASSOCIATED USES
UndeterminedMA49617A
Owner:NOVO NORDISK AS
COMPOUNDS CONTAINING A MUTANT KRAS SEQUENCE AND A LIPID AND THEIR USES
UndeterminedMA52435A
Owner:ELICIO THERAPEUTICS INC
Use of elsiglutide to treat gastrointestinal mucositis including chemotherapy-induced diarrhea
UndeterminedMA40623A
Owner:HELSINN HEALTHCARE SA +1
GADOLINIUM COMPLEX AND A CHELATOR LIGAND DERIVED FROM DIASTEREOISOMERICLY ENRICHED PCTA AND SYNTHESIS PROCESS
UndeterminedMA54624A
Owner:GUERBET SA
METHOD FOR TESTING THE EFFICIENCY OF AN EXHAUST LINE CATALYTIC CONVERTER FOR AN INTERNAL COMBUSTION ENGINE
ActiveMA54797A
Owner:STELLANTIS AUTO SAS
SYSTEM AND METHOD FOR READING AND ANALYZING BEHAVIOUR INCLUDING VERBAL, BODY, AND FACIAL EXPRESSIONS IN ORDER TO DETERMINE A PERSON'S CONGRUENCE
Owner:CM PROFILING SARL
LAMINATED ILLUMINATED GLAZING WITH A CAPACITIVE TOUCH DEVICE AND A LIGHT-EMITTING DIODE AND ITS MANUFACTURE
UndeterminedMA43012A
Owner:SAINT GOBAIN VITRAGE SA
CLOSED-ENDED DNA (CEDNA) AND USE IN PROCESSES FOR REDUCING THE IMMUNE RESPONSE RELATED TO GENE OR NUCLEIC ACID THERAPY
UndeterminedMA54826A
Owner:GENERATION BIO CO
ANTITUMORAL EFFECT ENHANCER USING A NEW BIPHENYL COMPOUND
UndeterminedMA50467A
Owner:TAIHO PHARMA CO LTD
USE OF EXOSOMES FOR THE TREATMENT OF DISEASES
UndeterminedMA45481A
Owner:BOARD OF RGT THE UNIV OF TEXAS SYST
Synthetic APELIN Fatty Acid Conjugates with an Improved Half-Life
UndeterminedMA41580A
Owner:NOVARTIS AG
Integrated, three-dimensional cell configuration, integrated cooling array and cell-based integrated circuit
UndeterminedMA40285A
Owner:HAT TEKNOLOJI AS
Cryptophycin Peptide and Conjugated Linkers, Useful in Therapy, and Their Preparation
UndeterminedMA50764A
Owner:SANOFI SA(FR)
Bacterial lactic acid composition for the treatment of bacterial vaginal infections caused by Gardnerella vaginalis and, possibly, concurrent fungal infections
UndeterminedMA45334A
Owner:PROBIOTICAL SPA
ANTI-LAG3 ANTIBODIES AND ANTIGEN BINDING FRAGMENTS
UndeterminedMA43576A
Owner:MERCK SHARP & DOHME CORP
SELECTION AND USE OF MELATONIN-PROMOTING BACTERIA TO REDUCE INFANT COLIC
ActiveMA50489Aavoid motilityavoid pain
Owner:BIOGAIA AB
Drug Delivery Devices and Systems for Local Drug Administration to the Upper Urinary Tract
ActiveMA54171A
Owner:JANSSEN BIOTECH INC
MAGNETIC-ACTIVATED CONTINUOUS ANALYTE SENSOR
UndeterminedMA53306A
Owner:F HOFFMANN LA ROCHE & CO AG +1
HETEROCYCLIC MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS
UndeterminedMA56443A
Owner:F HOFFMANN LA ROCHE & CO AG
GEL CONTAINING A MATRIX OF POLYURETHANE AND VEGETABLE OIL
UndeterminedMA44707A
Owner:ADVANCED POLYMER TECH CORP
DERIVATIVE OF POLYCYCLIC PYRIDONE SUBSTITUTE AND PROMEDICINAL PRODUCTS THEREOF
Owner:SHIONOGI & CO LTD
METHOD FOR MANAGING ELECTRICAL COMPONENTS IN A MOTOR VEHICLE
UndeterminedMA50058A
Owner:PSA AUTOMOBILES SA
GENETICALLY MODIFIED MOUSE MODELS FOR MULTIPLE MYELOMA
UndeterminedMA71607A
Owner:FUNDACION PARA LA INVESTIGACION MEDICA APLICADA
Compositions for increasing the half-life of a therapeutic agent in dogs and methods of use
UndeterminedMA54657A
Owner:INVETX INC
METHODS, MATERIALS AND TECHNIQUES FOR RECOVERING PRECIOUS METALS
UndeterminedMA45462A
Owner:ENVIROLEACH TECH INC
METHODS FOR DIFFERENTIATING BENIGN PROSTATIC HYPERPLASIA FROM PROSTATE CANCER
UndeterminedMA53141A
Owner:BERG LLC
METHOD FOR PREPARING GRANULES FOR HEATING AN INDUSTRIAL OVEN
UndeterminedMA54502A
Owner:SUBCOAL INT BV
INSTALLATION AND METHOD FOR INDUSTRIAL ENCAPSULATION OF THERMOLABILE SUBSTANCES
UndeterminedMA47222A
Owner:BIOINICIA SL +1
SEQUENTIAL BIOLOGICAL REACTOR AND METHOD IMPLEMENTING THE REACTOR
ActiveMA44388A
Owner:COHIN ENVIRONNEMENT
FRONT SECTION OF A VEHICLE'S BODY WITH SIDE REINFORCEMENT IN CASE OF A FRONT-ON COLLISION WITH ANOTHER VEHICLE
UndeterminedMA48937A
Owner:PSA AUTOMOBILES SA
Tetrahydroquinoline derivatives as bromodomaine inhibitors
UndeterminedMA40366A
Owner:GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD
NEW AMORPHIC DISPERSION OF CYCLOPROPANECARBOXYLIC ACID (5-{5-[ N'-(2-CHLORO-6-METHYLBENZOYL) HYDRAZINOCARBONYL] -2-METHYL-PHENYLETHYNYL}-PYRIDIN-2-YL) AMIDE
UndeterminedMA47798A
Owner:SUN PHARMA ADVANCED RESEARCH CO LTD
Monoclonal antibodies against her2 epitope and methods of use thereof
UndeterminedMA40049A
Owner:MERSANA THERAPEUTICS INC
Anti-PAD4 autoantibodies as biological markers of clinical response for the treatment of rheumatoid arthritis
UndeterminedMA45112A
Owner:MEDIMMUNE LTD
Anti-TNF antibodies, composition, methods and use for the treatment or prevention of type 1 diabetes
UndeterminedMA43982A
Owner:JANSSEN BIOTECH INC
LONG-ACTING COMBINATION COMPOSITIONS AND METHODS FOR FIGHTING HEPATITIS C
UndeterminedMA40817A
Owner:GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD
METHODS FOR REDUCING OR PREVENTING DAMAGE TO THE INTIMA CAUSED BY MECHANICAL STIMULATION OF ENDOTHELIAL CELLS
UndeterminedMA45307A
Owner:BIOGEN CHESAPEAKE LLC +2
AGENTS, USES AND METHODS FOR THE TREATMENT OF SYNUCLEINOPATHY
UndeterminedMA46836A
Owner:H LUNDBECK AS
DESIGN OF MODIFIED ANTIBODIES AND OTHER MOLECULES CONTAINING AN FC DOMAIN EXHIBITING ENHANCED AGONISM AND EFFECTOR FUNCTIONS
UndeterminedMA45919A
Owner:JANSSEN BIOTECH INC
METHOD FOR OPERATING A THERMAL CYCLE SYSTEM, THERMAL CYCLE SYSTEM AND METHOD FOR MODIFYING A THERMAL CYCLE SYSTEM
UndeterminedMA71233A
Owner:NODITECH AB
DYNAMICALLY SYMMETRICALLY EQUALIZED PRESSURE AND VOLUME AIR MANAGEMENT SYSTEM
UndeterminedMA48789A
Owner:BASE AIR MANAGEMENT LTD
PYRIMIDONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS AGAINST HIV-INFECTED CELLS
UndeterminedMA54549A
Owner:MERCK SHARP & DOHME CORP
METHOD FOR THE SERIES MANUFACTURING OF PRESTRESSED CONCRETE BEAMS WITH STIFFENING FOR BEAM AND JOINT JOIST FLOOR SYSTEMS
UndeterminedMA41305A
Owner:FABEMI QUALITE
COMPOSITIONS AND METHODS OF MANUFACTURING AND USING BISPECIFIC ANTIBODY
UndeterminedMA50102A
Owner:UNIV OF VIRGINIA PATENT FOUND
NEW BISPECIFIC ANTIGEN-BINDING MOLECULES CAPABLE OF BINDING SPECIFICALLY TO CD40 AND FAP
UndeterminedMA49039A
Owner:F HOFFMANN LA ROCHE & CO AG
Leveling spacers for laying wall cladding tiles and paving tiles with gaps
UndeterminedMA39006A
Owner:PROGRESS PROFILES
METHOD FOR PREVENTING DISEASES OF WHEAT, WHEAT SEED AND METHOD FOR INHIBITING LODGE DAMAGE ON WHEAT
UndeterminedMA54183A
Owner:KUMIAI CHEM IND CO LTD
NEW PYRROLO [2,3-D]PYRIMIDINE DERIVATIVES USED AS DUAL DYRK1 / CLK1 INHIBITORS
UndeterminedMA43021A
Owner:LES LAB SERVIER SA +1
CAPILLARY-BASED ELECTRO-SYNTHETIC OR ELECTRO-ENERGETIC CELLS
UndeterminedMA71662A
Owner:HYSATA PTY LTD
ANTIFUNGAL AGENTS, SUCH AS IBREXAFUNGERP, FOR THE DECOLONIZATION OF CANDIDA AURIS
UndeterminedMA55958A
Owner:SCYNEXIS INC
Crimp-on electrical connector with a protective element
UndeterminedMA50990A
Owner:AGC GLASS EUROPE SA